|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
EP1690531A3
(en)
*
|
1996-09-30 |
2010-01-20 |
Alza Corporation |
Dosage form and method for administering drug
|
|
ATE321529T1
(de)
*
|
1996-09-30 |
2006-04-15 |
Alza Corp |
Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
|
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
CA2265668C
(en)
*
|
1996-11-25 |
2005-08-23 |
Alza Corporation |
Methylphenidate tablet
|
|
US6962997B1
(en)
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
|
AU2012232984B2
(en)
*
|
1998-06-03 |
2015-10-29 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
AU2004200938B2
(en)
*
|
1998-06-03 |
2006-09-14 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
EP1083879B1
(en)
*
|
1998-06-03 |
2004-09-29 |
Alza Corporation |
Devices for providing prolonged drug therapy
|
|
KR100890537B1
(ko)
*
|
1998-06-03 |
2009-03-27 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
|
KR100827254B1
(ko)
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
|
DK1126826T6
(en)
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
|
US6673367B1
(en)
*
|
1998-12-17 |
2004-01-06 |
Euro-Celtique, S.A. |
Controlled/modified release oral methylphenidate formulations
|
|
AU4221300A
(en)
|
1999-04-06 |
2000-10-23 |
Kamal K. Midha |
Pharmaceutical dosage form for pulsatile delivery of (d-threo)-methylphenidate and a second cns stimulant
|
|
IL150657A0
(en)
*
|
2000-01-20 |
2003-02-12 |
Delsys Pharmaceutical Corp |
Multi-step drug dosage forms
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
ATE373472T1
(de)
*
|
2002-07-29 |
2007-10-15 |
Alza Corp |
Verfahren und dosierformen für die kontrollierte abgabe von paliperidon
|
|
AR041744A1
(es)
*
|
2002-10-31 |
2005-05-26 |
Alza Corp |
Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida
|
|
US7988993B2
(en)
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
|
JP2007506775A
(ja)
*
|
2003-09-26 |
2007-03-22 |
アルザ・コーポレーシヨン |
漸増する放出速度を表す制御放出製剤
|
|
CA2540308C
(en)
|
2003-09-26 |
2013-08-06 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
|
WO2015001488A1
(en)
|
2013-07-01 |
2015-01-08 |
Ranbaxy Laboratories Limited |
Extended-release tablets of paliperidone and processes of preparation thereof
|
|
CA2936746C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
|
MX2018007977A
(es)
*
|
2015-12-31 |
2018-11-09 |
Cadila Healthcare Ltd |
Forma farmaceutica osmotica de liberacion extendida que contiene una carga de clorhidrato de metilfenidato alta.
|
|
EP3501504A1
(en)
|
2017-12-22 |
2019-06-26 |
Pharmacia Polonica sp. z o.o. |
Modified release tablet of paliperidone and a process for the preparation thereof
|
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|